ABSTRACT

Cystic Fibrosis (CF) is the most common fatal genetic disease of Caucasians. The last several decades have seen a dramatic increase in survival of the CF patient. In 1960, the median survival age for CF patients was less than 5 years. Today CF patients can expect to live 30 years or more. The reasons for this dramatically improved outlook are protean. Included among the many contributing factors are new and more potent antibiotics, im­ proved nutritional support, more efficacious pancreatic enzyme formulations, and more effective airway clearance techniques.